The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and the MIT – Koch Institute for Integrative Cancer Research have announced a strategic collaboration to advance AI-enabled oncology research, translational science and bioconvergence innovation. Leveraging Abu Dhabi’s intelligent life science ecosystem, the partnership will connect world-class research […]
Abu Dhabi Biobank (ADBB), a strategic initiative between the Department of Health – Abu Dhabi, the regulator of the healthcare sector in the Emirate, and M42, a global health leader, announced a landmark collaboration with Bascom Palmer Eye Institute, part of the University of Miami Health System. Announced at the BIO International Convention 2026 in […]
Healthpoint, part of the M42 group, has supported a patient in reclaiming her daily life after years of living with lymphedema, through a specialised, multidisciplinary approach to care. For a long time, 37-year-old Maryam Al Rais adjusted her life around a condition she couldn’t fully control. The swelling in her leg was persistent, often painful, […]
Eli Lilly Drugstore LLC (Lilly) and the Department of Health – Abu Dhabi (DoH), regulator of the healthcare sector in Abu Dhabi, have signed a Memorandum of Understanding (MoU) at the BIO International Convention 2026, in San Diego, USA to address obesity and Alzheimer’s disease, two of the most pressing health challenges in the region. […]
Specialized Rehabilitation Hospital (SRH), a leading rehabilitation hospital under Capital Health, has broken ground on a major new extension in Abu Dhabi, marking the next phase in its development as an integrated hospital for rehabilitation and specialty care. The groundbreaking ceremony for the new extension was attended by H.E. Dr. Fayeza Saif Nasir Alyafe, Executive […]
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate of Abu Dhabi, and Novartis Middle East FZE today signed a Memorandum of Understanding to explore collaboration in genomics research, scientific capacity building, and advanced therapies, reinforcing their shared commitment to advancing healthcare innovation and improving patient outcomes. […]
Burjeel Holdings, a leading super-specialty healthcare group in the GCC listed on the Abu Dhabi Securities Exchange, successfully priced its inaugural USD 500 million Regulation S 5-year senior unsecured Sukuk offering due 2031 under its newly established USD 1.5 billion Senior Unsecured Sukuk Programme. The offering attracted significant demand from high-quality international and regional investors, […]
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Biocom California, one of the world’s largest life sciences associations representing more than 1,800 biotechnology, pharmaceutical and medical technology organisations, have announced a strategic partnership that will create a formal gateway between Abu Dhabi and California’s life […]
SEHA,a subsidiary of PureHealth, the largest healthcare group in the Middle East, has announced that SEHA Tawam Hospital will host the UAE and wider region’s first certified workshop on Low-Dose Radiotherapy (LDRT) for benign diseases, marking an important milestone in expanding the clinical applications of radiation therapy beyond oncology. Delivered over three days in collaboration […]
Burjeel Holdings PLC (“Burjeel” or “the Group”), a leading super-specialty healthcare services provider in the GCC listed on the Abu Dhabi Securities Exchange (SYMBOL: BURJEEL; ISIN: AEE01119B224), today announced that it has received first-time corporate credit ratings from S&P Global Ratings and Moody’s Ratings, alongside the establishment of a USD 1.5 billion Senior Unsecured Sukuk […]
